ææ°ã® Amgen Inc ã®æ ªåŒãã¥ãŒã¹ã決ç®ãã¢ããªã¹ãè©äŸ¡ãéèŠãªååã远跡ã§ããŸãã
9æ8æ¥ã®Novo Nordisk A/S (NVO) çµå€ã¯3.09%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
9æ8æ¥ã®Bristol-Myers Squibb Co (BMY) å€åãã¯3.25%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
9æ8æ¥ã®Vertex Pharmaceuticals Inc (VRTX) å€åãã¯3.06%äžèœïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
9æ8æ¥ã®Gilead Sciences Inc (GILD) å€åãã¯3.26%äžèœïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
9æ8æ¥ã®Amgen Inc (AMGN) å€åãã¯8.33%äžèœïŒå®å šãªåæ
8æ19æ¥ã®Amgen Inc (AMGN) å€åãã¯3.19%äžæïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±
8æ6æ¥ã®Mckesson Corp (MCK) å€åãã¯3.44%äžèœïŒå®å šãªåæ
8æ5æ¥ã®Mckesson Corp (MCK) çµå€ã¯5.08%äžæïŒå€åãã®èåŸã«ããèŠå
8æ5æ¥ã®Bristol-Myers Squibb Co (BMY) å€åãã¯3.10%äžèœïŒå®å šãªåæ
8æ5æ¥ã®Gilead Sciences Inc (GILD) å€åãã¯3.96%äžèœïŒå®å šãªåæ